137 related articles for article (PubMed ID: 29735173)
1. Pretransplant predictors of early mortality in adult recipients of liver transplantation in the MELD-Na Era.
Pozo-Laderas JC; Rodríguez-Perálvarez M; Muñoz-Villanueva MC; Rivera-Espinar F; Durban-García I; Muñoz-Trujillo J; Robles-Arista JC; Briceño-Delgado J
Med Intensiva (Engl Ed); 2019; 43(5):261-269. PubMed ID: 29735173
[TBL] [Abstract][Full Text] [Related]
2. Early postoperative mortality in liver transplant recipients involving indications other than hepatocellular carcinoma. A retrospective cohort study.
Pozo-Laderas JC; Guler I; Rodríguez-Perálvarez M; Robles JC; Mula A; López-Cillero P; de la Fuente C
Med Intensiva (Engl Ed); 2021 Oct; 45(7):395-410. PubMed ID: 34563340
[TBL] [Abstract][Full Text] [Related]
3. Region 11 MELD Na exception prospective study.
Fisher RA; Heuman DM; Harper AM; Behnke MK; Smith AD; Russo MW; Zacks S; McGillicuddy JW; Eason J; Porayko MK; Northup P; Marvin MR; Hundley J; Nair S
Ann Hepatol; 2012; 11(1):62-7. PubMed ID: 22166562
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
6. [The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].
Boin Ide F; Leonardi MI; Udo EY; Sevá-Pereira T; Stucchi RS; Leonardi LS
Arq Gastroenterol; 2008; 45(4):275-83. PubMed ID: 19148354
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma: impact of waiting list and pre-operative treatment strategies on survival of cadaveric liver transplantation in pre-MELD era in one center in Brazil].
Freitas AC; Parolin MB; Stadnik L; Coelho JC
Arq Gastroenterol; 2007; 44(3):189-94. PubMed ID: 18060269
[TBL] [Abstract][Full Text] [Related]
8. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
[TBL] [Abstract][Full Text] [Related]
9. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
[TBL] [Abstract][Full Text] [Related]
10. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
11. MELD and other predictors of survival after liver transplantation.
Brandão A; Fuchs SC; Gleisner AL; Marroni C; Zanotelli ML; Cantisani G;
Clin Transplant; 2009; 23(2):220-7. PubMed ID: 19210688
[TBL] [Abstract][Full Text] [Related]
12. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
[TBL] [Abstract][Full Text] [Related]
13. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
Mazumder NR; Atiemo K; Daud A; Kho A; Abecassis M; Levitsky J; Ladner DP
Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
[TBL] [Abstract][Full Text] [Related]
14. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
[TBL] [Abstract][Full Text] [Related]
15. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
16. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
17. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
[TBL] [Abstract][Full Text] [Related]
18. Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.
de Haas RJ; Lim C; Bhangui P; Salloum C; Compagnon P; Feray C; Calderaro J; Luciani A; Azoulay D
Hepatology; 2018 Jan; 67(1):204-215. PubMed ID: 28806477
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
Brandman D; Biggins SW; Hameed B; Roberts JP; Terrault NA
Liver Int; 2012 Jan; 32(1):158-64. PubMed ID: 22098119
[TBL] [Abstract][Full Text] [Related]
20. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
